Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Graft-Versus-Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 0 results

Early research (Phase 1)Study completedNCT04987333
What this trial is testing

Study of Efavaleukin Alfa in Healthy Chinese, Japanese, and Caucasian Participants

Who this might be right for
Inflammatory Diseases
Amgen 32
Testing effectiveness (Phase 2)Study completedNCT02406651
What this trial is testing

Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHD

Who this might be right for
Acute Graft vs Host Disease
EVIVE Biotechnology 30
Not applicableAvailableNCT04768907
What this trial is testing

Early Access Program With MaaT013 in Steroid-refractory Acute Gastrointestinal Graft Versus Host Disease

Who this might be right for
Acute Graft Versus Host Disease in IntestineSteroid Refractory GVHD
MaaT Pharma
Large-scale testing (Phase 3)UnknownNCT02506231
What this trial is testing

The Effect of Folinic Acid Rescue Following MTX GVHD Prophylaxis on Regimen Related Toxicity and Transplantation Outcome

Who this might be right for
Graft vs Host DiseaseAllogeneic Hematopoietic Cell TransplantationMucositis
Rabin Medical Center 160
Post-approval studies (Phase 4)Study completedNCT02156570
What this trial is testing

DAA-based Therapy for Recently Acquired Hepatitis C II (DAA = Directly Acting Antiviral)

Who this might be right for
Hepatitis C
Kirby Institute 20
Testing effectiveness (Phase 2)Ended earlyNCT00964665
What this trial is testing

Pharmacokinetic/Pharmacodynamic of Albinterferon Alfa-2b in Chronic Hepatitis B, eAg+, Infection Subjects

Who this might be right for
Chronic Hepatitis B
Novartis Pharmaceuticals 141
Post-approval studies (Phase 4)Study completedNCT00537537
What this trial is testing

To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB)

Who this might be right for
Hepatitis B, Chronic
Novartis Pharmaceuticals 100